Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.
d-(Arg)-Kyotorphin iontophoresis was investigated across intact and impaired skins in vitro. Iontophoretic flux increased from 68+/-12 to 538+/-116 nmol cm(-2) h(-1) when the peptide concentration in the anodal compartment was raised from 5 to 40 mM. Electromigration was the principal transport mechanism, accounting for approximately 70% of total peptide delivery. Reducing the number of competing ions in the formulation significantly increased iontophoretic flux but did not affect convective solvent flow. The latter was independent of peptide concentration indicating that skin permselectivity was not modified by kyotorphin transport. Total iontophoretic flux was unaffected when the stratum corneum was removed by tape-stripping (146+/-34 versus 150+/-26 nmol cm(-2) h(-1)). However, the contributions of the different transport mechanisms were significantly altered: (i) electromigration decreased, as more of the charge was carried by anions from the sub-dermal milieu; (ii) electroosmosis was absent; and (iii) passive permeation increased significantly. Transport rates across intact and impaired skin barriers were statistically indistinguishable when the donor electrolyte composition was modified; increased competition from anions was mitigated by the decreased Na+ levels in the formulation. Removal of Cl- ions from the receiver phase further increased peptide delivery, and also increased anodal electroosmosis.
Abla
Nada
N
School of Pharmaceutical Sciences, University of Geneva, 30 Quai Ernest-Ansermet, 1211 Geneva 4, Switzerland.
Naik
Aarti
A
Guy
Richard H
RH
Kalia
Yogeshvar N
YN
D000082:Acetaminophen / Q000008:administration & dosage / Q000493:pharmacokinetics; D000465:Algorithms; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004431:Ear, External / Q000378:metabolism; D004563:Electrochemistry; D006868:Hydrolysis; D066298:In Vitro Techniques; D007478:Iontophoresis; D009995:Osmosis; D010455:Peptides / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D011955:Receptors, Drug / Q000187:drug effects; D012869:Skin Absorption; D012964:Sodium / Q000502:physiology; D012965:Sodium Chloride / Q000494:pharmacology; D012997:Solvents; D013552:Swine
D010455:Peptides; D011955:Receptors, Drug; D012997:Solvents; D000082:Acetaminophen; D012965:Sodium Chloride; D012964:Sodium